Connect with us
In the fight against coronavirus, the Tübingen-based biotech company Curevac plans to massively expand its production capacities. That was announced by a Curevac spokesperson on Thursday,...
In the fight against the coronavirus pandemic, the Tübingen-based biotech company Curevac intends to start mass phase III tests before the end of the year. The...
The race around the clock to find a vaccine that would end the coronavirus pandemic is now closer to the finish line. The vaccine candidate developed...
The company Innoup from Navarra has obtained a grant from the Center for the Development of Industrial Technology to implement a vaccine based on nanoparticles. Innoup...
The Basque company Touchlight has obtained a grant from the Center for the Development of Industrial Technology to advance a tool for the rapid manufacture of...
Along with the Federal Government, corporations around the world have seen their balance sheets suffer. Wall Street is hoping that all of these troubling situations will...
An impressive number of biotech companies have entered the race to find a vaccine that would put an end to the coronavirus pandemic. Among them are...
In the race for a reliable vaccine against the new coronavirus, five companies from the international biotech sector have become the focus of investors in recent...
The company MSD is acquiring a 100% stake in Themis Bioscience through its European subsidiary. The aws Gründerfonds, which has held a stake in Themis since...
Public and private laboratories are scrambling to develop a vaccine against COVID-19. All vaccine technologies, even the most experimental, are being used. Only eight companies (four...